Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Adrenal gland disease is common in ferrets and causes hair loss and other symptoms.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

Finasteride may cause kidney damage.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Early diagnosis and treatment with Leuprolide are key for children with precocious puberty.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Female hair loss patients more likely to have dry eye and gland issues.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

A new gene, JMJD1C, may affect testosterone levels in men.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Gray hair regained color after thyroid hormone treatment.

The index to ring finger ratio may indicate disease severity in female ankylosing spondylitis patients, but not in males.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.